{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:39:16Z","timestamp":1781656756290,"version":"3.54.5"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007214","name":"Velux Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007214","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Non\u2010invasive retinal markers of disease activity could pave the way for individualized treatment in neovascular age\u2010related macular degeneration (<jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content>). We aimed to evaluate if retinal vascular oxygen saturation and calibres could predict the initial treatment response after a loading phase of intravitreal aflibercept in <jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A total of 149 eyes were included (<jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content>,<jats:italic> n<\/jats:italic>\u00a0=\u00a076; dry <jats:styled-content style=\"fixed-case\">AMD<\/jats:styled-content>,<jats:italic> n<\/jats:italic>\u00a0=\u00a030; normal eyes <jats:italic>n<\/jats:italic>\u00a0=\u00a043). Of these, 57 treatment\u2010na\u00efve eyes with <jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content> received three monthly injections with 2.0\u00a0mg aflibercept and were subsequently stratified according to functional and structural response according to development in best\u2010corrected visual acuity and macular retinal thickness. The retinal vascular oxygen saturation and calibres were measured prior to treatment and 1\u00a0month after the third injection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with <jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content> and dry <jats:styled-content style=\"fixed-case\">AMD<\/jats:styled-content> had higher retinal arteriolar oxygen saturation as compared to normal eyes (94.3% versus 95.2% versus 92.6%, p\u00a0=\u00a00.04). Thirty\u2010nine (68.4%) and 12 (21.1%) eyes with <jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content> were functional and structural responders. After the loading phase, structural nonresponders developed a higher retinal arteriolar (95.3% versus 93.3%, p\u00a0=\u00a00.03) and venular (64.7% versus 59.4%, p\u00a0=\u00a00.02) oxygen saturation, and responders developed a lower retinal arteriolar calibre (118.0 versus 114.3\u00a0<jats:italic>\u03bc<\/jats:italic>m, p\u00a0&lt;\u00a00.01). In a multiple logistic regression model, increasing retinal venular oxygen saturation associated with a negative structural treatment outcome (odds ratio 1.17 for each 1% increment after the loading phase, 95% confidence interval 1.01\u20131.36, p\u00a0=\u00a00.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Changes in the retinal venular oxygen saturation associate independently with initial treatment response in <jats:styled-content style=\"fixed-case\">nAMD<\/jats:styled-content>, but functional and structural retinal measurements prior to treatment could not predict the treatment response.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aos.13996","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T05:59:47Z","timestamp":1544767187000},"page":"525-531","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Retinal metabolic and structural alterations in response to aflibercept treatment in neovascular age\u2010related macular degeneration"],"prefix":"10.1111","volume":"97","author":[{"given":"Ditte B.","family":"Jakobsen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology Odense University Hospital Odense Denmark"},{"name":"Department of Clinical Research University of Southern Denmark Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3556-8531","authenticated-orcid":false,"given":"Thomas L.","family":"Torp","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Odense University Hospital Odense Denmark"},{"name":"Department of Clinical Research University of Southern Denmark Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Stefansson","sequence":"additional","affiliation":[{"name":"University of Iceland Reykjavik Iceland"},{"name":"Landspitali University Hospital Reykjavik Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-0381","authenticated-orcid":false,"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[{"name":"Department of Clinical Research University of Southern Denmark Odense Denmark"},{"name":"Centre for Public Health Queen's University Belfast Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5019-0736","authenticated-orcid":false,"given":"Jakob","family":"Grauslund","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Odense University Hospital Odense Denmark"},{"name":"Department of Clinical Research University of Southern Denmark Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200502000-00001"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20305"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.10.018"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-6-713"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040031330019"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2432664"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6646"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9912"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12294"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.006"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/09286586.2015.1066396"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000477180"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12008"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02209.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(05)80078-X"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.017"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-014-9991-z"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13229"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00736.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.09.003"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2011.00662.x"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2017.1354217"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7689"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.13996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aos.13996","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.13996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T22:19:18Z","timestamp":1694211558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.13996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1111\/aos.13996"],"URL":"https:\/\/doi.org\/10.1111\/aos.13996","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"2018-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}